Injectable shear-thinning hydrogels promote oligodendrocyte progenitor cell survival and remyelination in the central nervous system
Science Advances · 2024
DOI: 10.1126/sciadv.adk9918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Ashis Kumar Podder und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, University at Buffalo, The State University of New York (SUNY), Buffalo, NY, USA. Hauptthemen laut MEDLINE: Hydrogels, Oligodendrocyte Precursor Cells, Remyelination, Cell Survival. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Cell therapy for the treatment of demyelinating diseases such as multiple sclerosis is hampered by poor survival of donor oligodendrocyte cell preparations, resulting in limited therapeutic outcomes. Excessive cell death leads to the release of intracellular alloantigens, which likely exacerbate local inflammation and may predispose the graft to eventual rejection. Here, we engineered innovative cell-instructive shear-thinning hydrogels (STHs) with tunable viscoelasticity and bioactivity for minimally invasive delivery of primary human oligodendrocyte progenitor cells (hOPCs) to the brain of a shiverer/rag2 mouse, a model of congenital hypomyelinating disease. The STHs enabled immobilization of prosurvival signals, including a recombinantly designed bidomain peptide and platelet-derived growth factor. Notably, STHs reduced the death rate of hOPCs significantly, promoted the production of myelinating oligodendrocytes, and enhanced myelination of the mouse brain 12 weeks post-implantation. Our results demonstrate the potential of STHs loaded with biological cues to improve cell therapies for the treatment of devastating myelopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biological Engineering, University at Buffalo, The State University of New York (SUNY), Buffalo, NY, USA.
- Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, Buffalo, NY, USA.
- Neuroscience Program, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, Buffalo, NY, USA.
- Department of Biomedical Engineering, University at Buffalo, SUNY, Buffalo, NY, USA.
- Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, SUNY, Buffalo, NY, USA.
- Center of Cell, Gene and Tissue Engineering, University at Buffalo, SUNY, Buffalo, NY, USA.
ORCID-Profile: Ashis Kumar Podder, Mohamed Alaa Mohamed, Richard A Seidman, Pedro Lei, Fraser J Sim, Stelios T Andreadis
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
Zitieren
APA
Kumar Podder, A., Mohamed, M. A., Seidman, R. A., Tseropoulos, G., Polanco, J. J., Lei, P., Sim, F. J., & Andreadis, S. T. (2024). Injectable shear-thinning hydrogels promote oligodendrocyte progenitor cell survival and remyelination in the central nervous system. Science Advances. https://doi.org/10.1126/sciadv.adk9918
Vancouver
Kumar Podder A, Mohamed MA, Seidman RA, Tseropoulos G, Polanco JJ, Lei P, et al. Injectable shear-thinning hydrogels promote oligodendrocyte progenitor cell survival and remyelination in the central nervous system. Science Advances. 2024. doi:10.1126/sciadv.adk9918
BibTeX
@article{KumarPodder2024,
author = {Kumar Podder, Ashis and Mohamed, Mohamed Alaa and Seidman, Richard A and Tseropoulos, Georgios and Polanco, Jessie J and Lei, Pedro and Sim, Fraser J and Andreadis, Stelios T},
title = {Injectable shear-thinning hydrogels promote oligodendrocyte progenitor cell survival and remyelination in the central nervous system},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adk9918}
}
EUVIMED